Frontiers in Clinical Diabetes and Healthcare

Dapagliflozin & pioglitazone combination therapy in T2DM with or without MASLD - a systematic review and meta-analysis: PRO-2 study

By Shashank R Joshi, Shambo Samrat Samajdar, Arvind Gupta, Thamburaj Anthuvan

ReviewInterventions

The paper

Shashank R Joshi, Shambo Samrat Samajdar, Arvind Gupta, Thamburaj Anthuvan

Lilavati Hospital & Research Centre; Savitribai Phule Pune University

Frontiers in Clinical Diabetes and Healthcare, 20 Jul 2026

doi.org/10.3389/fcdhc.2026.1733995 PubMed 42548745

Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk